SCHEMBL7083365

SCHEMBL7083365

CCCC(=O)NS(=O)(=O)c1ccccc1NC(=O)c1cccc(Oc2cccs2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
NPC1 O15118 3/20 0.42
ALDH1A1 P00352 3/20 0.42
PKM P14618 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
GCK P35557 1/20 0.42
ADRB2 P07550 1/20 0.41
MTNR1B P49286 1/20 0.40
HPGD P15428 1/20 0.40
MAPT P10636 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
F10 P00742 1/20 0.39
PLG P00747 1/20 0.39
PLAT P00750 1/20 0.39
KLK1 P06870 1/20 0.39
PRSS1 P07477 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7080300 0.88 ALDH1A1 (0.48) RAB9AMEN1KMT2ANPC1ALDH1A1
SCHEMBL7077439 0.86 ALDH1A1 (0.44) RAB9AMEN1KMT2ANPC1ALDH1A1
SCHEMBL7076725 0.83 MTNR1B (0.48) RAB9AMEN1KMT2ANPC1ALDH1A1
SCHEMBL7080254 0.82 MEN1 (0.47) RAB9AMEN1KMT2ANPC1ALDH1A1
SCHEMBL7080642 0.82 ALDH1A1 (0.42) RAB9AMEN1KMT2ANPC1ALDH1A1
SCHEMBL7078520 0.80 ALDH1A1 (0.53) MEN1KMT2AALDH1A1SMN1; SMN2HPGD
SCHEMBL7080328 0.78 MEN1 (0.48) RAB9AMEN1KMT2ANPC1SMN1; SMN2
SCHEMBL7083338 0.78 MEN1 (0.44) RAB9AMEN1KMT2ANPC1ALDH1A1
SCHEMBL7081565 0.77 USP2 (0.47) RAB9AMEN1KMT2ANPC1ALDH1A1
SCHEMBL7047672 0.77 SMPD1 (0.55) MEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN RAB9A 3579/4885MEN1 4502/4885KMT2A 934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.